Rapid Medical’s TIGERTRIEVER 13 Shows Positive Outcomes in DISTALS Trial
Rapid Medical has reported promising 90-day outcomes from the DISTALS trial for its TIGERTRIEVER 13 device, demonstrating its safety and efficacy in treating distal ischemic stroke.
MAASTRICHT, Netherlands & YOKNEAM, Israel–(BUSINESS WIRE)– #DMVO–Rapid Medical reports DISTALS trial results showing the safety and efficacy of TIGERTRIEVER 13 in distal ischemic stroke, with encouraging outcomes.